Xpert BCR-ABL Ultra ® Xpert BCR-ABL Ultra ® Sensitivity, precision and ease of use In Vitro Diagnostic Medical Device

Cepheid’s Xpert BCR-ABL Ultra test solves many of the present challenges in monitoring patients with Chronic Myeloid Leukaemia, including accuracy (remarkably precise International Scale calibration) and speed (in hours) of reporting molecular response. These performance characteristics are important from initiation of therapy to the deep remissions possible with the array of available therapeutic options." Leader, Myeloproliferative Neoplasms Program. Memorial Sloan Kettering Cancer Center THE SOLUTION Each year 1.0-1.5 newly diagnosed Chronic Myelogenous Leukaemia (CML) patients are identified...

THE IMPACT • Clinician: Same day information supports informed clinical decisions, including inclusion in treatment discontinuation research • Patient: Faster results reduce patient anxiety9 • Laboratory: Flexibility and simplicity for more streamlined workflow Move your lab forward • Decrease costs: Eliminates need for standard curve and replicate testing • Optimised lab organisation: Free up technician time for other lab services • Flexible: Any number of samples, any day of the week with a fixed cost per reportable result • Simple Reporting: One page report with results aligned to the IS PROCESS...

Easy Same-Day Process 1 Transfer the Wash Reagent into Chamber 1 Pipette entire contents of prepared sample (~4.5mL) into the sample chamber (S) 3 Insert cartridge and start test Xpert® BCR-ABL Ultra provides individual on-demand measurement of BCR-ABL transcript levels down to 4.5 log reduction for individuals with CML. Xpert BCR-ABL Ultra CATALOG INFORMATION References: 1. Goldman J. Chronic Myeloid Leukemia. 2008, Leukemia, Vol. 37, pp. 195-197. 2. Huang X, et al. Estimations of the increasing prevalence and plateau prevalence of chronic myeloid leukemia in the era of tyrosine kinase inhibitor...